Payment overview · 2025
General Payments
$19.88
1 reported records · 1 companies
Healthcare provider profile · identity verified
Farhan Khan, MD
Allopathic & Osteopathic Physicians|Internal Medicine · FLINT, MI · NPI 1023081742
Verified facts
What the public records show
CMS Open Payments records show Farhan Khan, MD received $19.88 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 216 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $19.88 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.88 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $19.88 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $19.88 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 216 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
216 | 46 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 540 | 180 |
| Losartan Potassium | Losartan Potassium | 501 | 165 |
| Levothyroxine Sodium | Levothyroxine Sodium | 452 | 125 |
| Atorvastatin Calcium | Atorvastatin Calcium | 448 | 149 |
| Simvastatin | Simvastatin | 409 | 125 |
| Metoprolol Succinate | Metoprolol Succinate | 376 | 117 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 360 | 130 |
| Lisinopril | Lisinopril | 304 | 96 |
| Omeprazole | Omeprazole | 276 | 110 |
| Tamsulosin Hcl | Tamsulosin Hcl | 268 | 87 |
| Metformin Hcl | Metformin Hcl | 259 | 90 |
| Gabapentin | Gabapentin | 218 | 77 |
| Ozempic | Semaglutide | 216 | 46 |
| Jardiance | Empagliflozin | 197 | 50 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 196 | 70 |
| Clopidogrel | Clopidogrel Bisulfate | 186 | 61 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 184 | 54 |
| Metoprolol Tartrate | Metoprolol Tartrate | 173 | 59 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 172 | 44 |
| Meloxicam | Meloxicam | 164 | 48 |
| Eliquis | Apixaban | 162 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 154 | 50 |
| Montelukast Sodium | Montelukast Sodium | 152 | 54 |
| Tramadol Hcl | Tramadol Hcl | 151 | 48 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 150 | 44 |
| Famotidine | Famotidine | 148 | 51 |
| Allopurinol | Allopurinol | 147 | 48 |
| Mounjaro | Tirzepatide | 143 | 30 |
| Sertraline Hcl | Sertraline Hcl | 130 | 45 |
| Potassium Chloride | Potassium Chloride | 128 | 39 |
| Carvedilol | Carvedilol | 123 | 42 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 123 | 27 |
| Trazodone Hcl | Trazodone Hcl | 117 | 43 |
| Alprazolam | Alprazolam | 113 | 29 |
| Tizanidine Hcl | Tizanidine Hcl | 110 | 28 |
| Furosemide | Furosemide | 105 | 45 |
| Baclofen | Baclofen | 104 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 102 | 37 |
| Duloxetine Hcl | Duloxetine Hcl | 100 | 31 |
| Prednisone | Prednisone | 98 | 60 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 92 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 92 | 45 |
| Nifedipine Er | Nifedipine | 91 | 33 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 87 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 84 | 29 |
| Spironolactone | Spironolactone | 80 | 29 |
| Novolog Flexpen | Insulin Aspart | 72 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 71 | 27 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 69 | 59 |
| Buspirone Hcl | Buspirone Hcl | 69 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 68 | 18 |
| Ezetimibe | Ezetimibe | 66 | 22 |
| Azithromycin | Azithromycin | 64 | 53 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 64 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 61 | 16 |
| Atenolol | Atenolol | 58 | 23 |
| Farxiga | Dapagliflozin Propanediol | 55 | 16 |
| Ibuprofen | Ibuprofen | 54 | 23 |
| Bumetanide | Bumetanide | 53 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 52 | 33 |
| Fluoxetine Hcl | Fluoxetine Hcl | 51 | 16 |
| Clonazepam | Clonazepam | 50 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 50 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 47 | 15 |
| Methylprednisolone | Methylprednisolone | 46 | 42 |
| Januvia | Sitagliptin Phosphate | 45 | 12 |
| Naproxen | Naproxen | 45 | 21 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 44 | 17 |
| Nystatin | Nystatin | 44 | 30 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 42 | 18 |
| Clonidine Hcl | Clonidine Hcl | 41 | 15 |
| Dicyclomine Hcl | Dicyclomine Hcl | 41 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 41 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 41 | 14 |
| Pregabalin | Pregabalin | 41 | 13 |
| Bupropion Hcl | Bupropion Hcl | 40 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 40 | 14 |
| Finasteride | Finasteride | 39 | 13 |
| Meclizine Hcl | Meclizine Hcl | 38 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | 21 |
| Torsemide | Torsemide | 37 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 36 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 36 | 24 |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | 11 |
| Myrbetriq | Mirabegron | 35 | suppressed |
| Trulicity | Dulaglutide | 35 | suppressed |
| Fluconazole | Fluconazole | 34 | 27 |
| Celecoxib | Celecoxib | 33 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 33 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 33 | 17 |
| Donepezil Hcl | Donepezil Hcl | 32 | 15 |
| Bupropion Xl | Bupropion Hcl | 31 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 31 | suppressed |
| Amoxicillin | Amoxicillin | 30 | 28 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Ramipril | Ramipril | 30 | suppressed |
| Brilinta | Ticagrelor | 29 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 29 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 29 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 28 | 11 |
| Cephalexin | Cephalexin | 28 | 19 |
| Entresto | Sacubitril/Valsartan | 28 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | 12 |
| Lactulose | Lactulose | 28 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 28 | 11 |
| Topiramate | Topiramate | 28 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 27 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 20 |
| Valacyclovir | Valacyclovir Hcl | 27 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Glipizide Er | Glipizide | 26 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 25 | 15 |
| Ondansetron Odt | Ondansetron | 25 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 24 | 15 |
| Estradiol | Estradiol | 24 | 13 |
| Mirtazapine | Mirtazapine | 24 | 11 |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 23 |
| Symbicort | Budesonide/Formoterol Fumarate | 24 | 11 |
| Xarelto | Rivaroxaban | 24 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 23 | suppressed |
| Lovastatin | Lovastatin | 23 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Gemfibrozil | Gemfibrozil | 22 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Repatha Syringe | Evolocumab | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 19 |
| Clobetasol Propionate | Clobetasol Propionate | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 16 |
| Pioglitazone Hcl | Pioglitazone Hcl | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 20 | suppressed |
| Acyclovir | Acyclovir | 19 | 13 |
| Chlorthalidone | Chlorthalidone | 19 | 12 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Primidone | Primidone | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Glimepiride | Glimepiride | 17 | suppressed |
| Glipizide | Glipizide | 17 | suppressed |
| Linzess | Linaclotide | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Olanzapine | Olanzapine | 17 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Armour Thyroid | Thyroid,pork | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 12 |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Synthroid | Levothyroxine Sodium | 16 | suppressed |
| Constulose | Lactulose | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | 14 |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Invokana | Canagliflozin | 14 | suppressed |
| Levetiracetam Er | Levetiracetam | 14 | suppressed |
| Loperamide | Loperamide Hcl | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Mirabegron Er | Mirabegron | 14 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Epinephrine | Epinephrine | 13 | suppressed |
| Lamotrigine Er | Lamotrigine | 13 | suppressed |
| Levetiracetam | Levetiracetam | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Febuxostat | Febuxostat | 12 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 12 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 12 | 11 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 12 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Etodolac | Etodolac | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Sulfasalazine | Sulfasalazine | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
| Zafirlukast | Zafirlukast | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.88 · 1 records | Novo Nordisk Inc | Ozempic, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error